198 related articles for article (PubMed ID: 23993342)
21. Amino Acid Metabolism Abnormity and Microenvironment Variation Mediated Targeting and Controlled Glioma Chemotherapy.
An S; Lu X; Zhao W; Sun T; Zhang Y; Lu Y; Jiang C
Small; 2016 Oct; 12(40):5633-5645. PubMed ID: 27571928
[TBL] [Abstract][Full Text] [Related]
22. Polymersomes conjugated with des-octanoyl ghrelin and folate as a BBB-penetrating cancer cell-targeting delivery system.
Chen YC; Chiang CF; Chen LF; Liang PC; Hsieh WY; Lin WL
Biomaterials; 2014 Apr; 35(13):4066-81. PubMed ID: 24513319
[TBL] [Abstract][Full Text] [Related]
23. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
[TBL] [Abstract][Full Text] [Related]
24. Choline Derivate-Modified Doxorubicin Loaded Micelle for Glioma Therapy.
Li J; Yang H; Zhang Y; Jiang X; Guo Y; An S; Ma H; He X; Jiang C
ACS Appl Mater Interfaces; 2015 Sep; 7(38):21589-601. PubMed ID: 26356793
[TBL] [Abstract][Full Text] [Related]
25. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W
J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115
[TBL] [Abstract][Full Text] [Related]
26. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
27. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
[TBL] [Abstract][Full Text] [Related]
28. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J
Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684
[TBL] [Abstract][Full Text] [Related]
29. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.
Ren J; Shen S; Wang D; Xi Z; Guo L; Pang Z; Qian Y; Sun X; Jiang X
Biomaterials; 2012 Apr; 33(11):3324-33. PubMed ID: 22281423
[TBL] [Abstract][Full Text] [Related]
30. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
Chen H; Qin Y; Zhang Q; Jiang W; Tang L; Liu J; He Q
Eur J Pharm Sci; 2011 Sep; 44(1-2):164-73. PubMed ID: 21782939
[TBL] [Abstract][Full Text] [Related]
31. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.
Zong T; Mei L; Gao H; Cai W; Zhu P; Shi K; Chen J; Wang Y; Gao F; He Q
Mol Pharm; 2014 Jul; 11(7):2346-57. PubMed ID: 24893333
[TBL] [Abstract][Full Text] [Related]
32. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.
Lu W; Sun Q; Wan J; She Z; Jiang XG
Cancer Res; 2006 Dec; 66(24):11878-87. PubMed ID: 17178885
[TBL] [Abstract][Full Text] [Related]
33. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations.
Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z
ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622
[TBL] [Abstract][Full Text] [Related]
34. Behavior and anti-glioma effect of lapatinib-incorporated lipoprotein-like nanoparticles.
Gao H; Yang Z; Cao S; Xi Z; Zhang S; Pang Z; Jiang X
Nanotechnology; 2012 Nov; 23(43):435101. PubMed ID: 23060604
[TBL] [Abstract][Full Text] [Related]
35. Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats.
Pang Z; Feng L; Hua R; Chen J; Gao H; Pan S; Jiang X; Zhang P
Mol Pharm; 2010 Dec; 7(6):1995-2005. PubMed ID: 20957995
[TBL] [Abstract][Full Text] [Related]
36. c(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma.
Huang Y; Liu W; Gao F; Fang X; Chen Y
Int J Nanomedicine; 2016; 11():1629-41. PubMed ID: 27143884
[TBL] [Abstract][Full Text] [Related]
37. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
Pollack IF; Erff M; Ashkenazi A
Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
[TBL] [Abstract][Full Text] [Related]
38. Nanoscaled poly(L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer.
Li M; Song W; Tang Z; Lv S; Lin L; Sun H; Li Q; Yang Y; Hong H; Chen X
ACS Appl Mater Interfaces; 2013 Mar; 5(5):1781-92. PubMed ID: 23410916
[TBL] [Abstract][Full Text] [Related]
39. Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats.
Hu J; Zhang X; Wen Z; Tan Y; Huang N; Cheng S; Zheng H; Cheng Y
Oncotarget; 2016 Nov; 7(45):73681-73696. PubMed ID: 27655664
[TBL] [Abstract][Full Text] [Related]
40. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
